The lack of survival differences in randomised trials in CLL may be related to the effect of second line therapies. A report from the LRF CLL4 trial.

The lack of survival differences in randomised trials in CLL may be related to the effect of second line therapies. A report from the LRF CLL4 trial.

Bibliographic Details
Main Authors: Catovsky, D, Else, M, Richards, S, Hillmen, P
Format: Conference item
Published: 2006

Similar Items